✦ LIBER ✦

101 Combinatorial cancer therapy using a pharmacological inhibitor of indoleamine 2,3-dioxygenase (IDO), a target of the cancer suppression gene Bin1

✍ Scribed by A.J. Muller; J.B. DuHadaway; E. Sutanto-Ward; P.S. Donover; G.C. Prendergast

Book ID: 118621285
Publisher: Elsevier Science
Year: 2004
Tongue: English
Weight: 145 KB
Volume: 2
Category: Article
ISSN: 1359-6349
DOI: 10.1016/s1359-6349(04)80109-5

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

101 Combinatorial cancer therapy using a

101 Combinatorial cancer therapy using a pharmacological inhibitor of indoleamine 2,3-dioxygenase (IDO), a target of the cancer suppression gene Bin1

✍ A.J. Muller; J.B. DuHadaway; E. Sutanto-Ward; P.S. Donover; G.C. Prendergast 📂 Article 📅 2004 🏛 Elsevier Science 🌐 English ⚖ 145 KB

the reduction of 17AAG by NQO1 is relatively stable to autooxidation and formation of the 17AAG hydroquinone may allow for increased levels of 17AAG intracellular drug accumulation via a slow autooxidation process. Another implication of the data is that the 17AAG hydroquinone may represent an alter

Inhibition of indoleamine 2,3-dioxygenas

Inhibition of indoleamine 2,3-dioxygenase, an immunoregulatory target of the cancer suppression gene Bin1, potentiates cancer chemotherapy

✍ Muller, Alexander J; DuHadaway, James B; Donover, P Scott; Sutanto-Ward, Erika; 📂 Article 📅 2005 🏛 Nature Publishing Group 🌐 English ⚖ 873 KB

Highlights at the gate of tryptophan cat

Highlights at the gate of tryptophan catabolism: a review on the mechanisms of activation and regulation of indoleamine 2,3-dioxygenase (IDO), a novel target in cancer disease

✍ Antonio Macchiarulo; Emidio Camaioni; Roberto Nuti; Roberto Pellicciari 📂 Article 📅 2008 🏛 Springer 🌐 English ⚖ 632 KB